The plasmid pT7 was constructed by amplifying pT7tet by PCR with the following oligos:
The PCR product was digested with AarI, and the purified digestion product was circularized by ligation.
To build pKSGFP, the EGFP coding sequence was amplified from pDEST17-EGFP using T7 promoter and T7 terminator primers. The PCR product and pBluescript II KS (+) were each digested with XbaI and EcoRV and ligated to form pKSGFP. To construct pT7tet, pGFP-ASV (49) was amplified by PCR using the following primers:
The PCR product was digested with AarI and was ligated to the following annealed oligos coding for the T7tet13 promoter:
To construct pT7tet2, pGFP-ASV was amplified by PCR using the same primers as for making pT7tet. The PCR product was digested with AarI and was ligated to the following annealed oligos coding for the T7tet19 promoter:
5' TCGCTAATACGACTCACTATAGGGAGATCGTCCCTATCAGTGATAGAGATCT 5' GTACAGATCTCTATCACTGATAGGGACGATCTCCCTATAGTGAGTCGTATTA pT7tet-RBSII was constructed by amplifying pT7tet using the oligos below, digesting the PCR product with AarI, and circularizing the purified digestion product by ligation:
5' AACTGTCACCTGCATCTGGAGAAATTAAGCATGCGTAAAGGAGAAGAACTTTTC 5' AACTGTCACCTGCATCTCTCCTCTTTAATTCAATGAATTCGGTCAGTGCGTC pT7tet-RBSg10 was constructed by amplifying pT7tet using the oligos below, digesting the PCR product with AarI, and circularizing the purified digestion product by ligation:
pT7tet-RBS35 was constructed by amplifying pT7tet using the oligos below, digesting the PCR product with AarI, and circularizing the purified digestion product by ligation:
pT7tet-RBSA was constructed by amplifying pT7tet using the oligos below, digesting the PCR product with AarI, and circularizing the purified digestion product by ligation:
To construct pUC-T7tet, pClpP was used as a parent plasmid. pClpP was constructed by first amplifying the pUC-19 vector using the following oligos:
To construct the insert for pClpP, a colony PCR of MG1655 E. coli was performed using the following oligos:
The two PCR products were digested with AarI, and the purified digestion products were ligated. Then, pClpP was amplified with the following oligos:
To construct the insert for pUC-T7tet, pDEST17-EGFP was amplified with the follwing primers:
Finally, the pClpP and pDEST17-EGFP PCR products were digested with AarI, and the purified digestion products were ligated.
To construct pUC-T7tet-T7term, pUCT7tet was first amplified by PCR with the following oligos:
The, to create the insert, pKSGFP was amplified by PCR using the following oligos:
The two PCR products were digested by AarI, purified, and ligated.
To construct pT7tetKS, pKSGFP was amplified using the following primers:
The PCR product was digested with AarI, and the purified product was circularized by ligation.
To construct pT7tetKS-ASV, pT7tetKS was amplified using the following oligos:
pGFP-ASV was amplified using the following oligos:
The resulting PCR products were digested by AarI, and the purified digestion products were ligated.
To construct pT7tetKS-SF, pT7tetKS was amplified using the following oligos:
pET-sfGFP (89)was amplified using the following oligos:
The resulting PCR products were digested by AarI, and the purified digestion products were ligated. To build pLacOGFP, the EGFP coding sequence was amplified from pKSGFP and inserted into pET15b between NdeI and HindIII to form an intermediate construct pGFPpET15b. The pGFPpET15b plasmid was digested using BglII and HindIII, and the digestion product containing the T7 promoter-LacO-RBS-GFP-Terminator sequence was inserted into pET3a.
To construct pLacOIDGFP, the LacOID operator region was inserted into pLacOGFP using the following PCR primers:
Fwd OID primer: 5' AATTGTGAGCGCTCACAATTGAAATAATTTTGTTTAACTTT revpET3a primer: 5' /Phos/CCCTATAGTGAGTCGTATTAATTTCGCGG To construct pT7LacI, the coding sequence for lac repressor was amplified from pFNK-101 (90) and the start codon was mutated from GTG to ATG using the following PCR primers:
Both the lacI PCR product and the pET3a vector were digested using NdeI and BamHI, and resulting products were ligated.
To construct pET-TetRHis, pET-sfGFP was amplified by PCR using the following primers:
pTetRgfp was amplified using the following primers:
The PCR products were digested with AarI, purified, and ligated. pCtltetKS was constructed by amplifying pKSGFP using the following primers:
To create the insert, pTetRgfp was amplified by PCR with the following primers:
The resulting products were digested with AarI, purified, and ligated.
To construct pLacI-GFP, the lacI coding sequence and ribosome binding site were amplified from pT7LacI using the following primers:
The EGFP coding sequence along with ribosome binding sites were amplified from pKSGFP using the following primers:
The PCR product containing the lacI coding sequence was digested with XbaI and BamHI, while the PCR product containing the coding sequence for EGFP was digested with BamHI and HindIII. pBluescript II KS (+) was digested with XbaI and HindIII and the products were then ligated and transformed.
To construct pGFP-LacI, the GFP coding sequence and ribosome binding site were amplified from pKSGFP using the following primers:
The lacI coding sequence and ribosome binding site were amplified from pT7LacI using the following primers:
The PCR product containing the EGFP coding sequence was digested with XbaI and SphI while the PCR product containing the coding sequence for lacI was digested with SphI and HindIII. pBluescript II KS (+) was digested with XbaI and HindIII and the products were then ligated and transformed. pNFB-T7tet was constructed by amplifying pTetRgfp using the following oligos:
The PCR product was digested with AarI, the purified digestion product was ligated to the annealed oligos below encoding the T7tet13 promoter:
5' TCGCTAATACGACTCACTATAGGGTCCCTATCAGTGATAGAGA 5' GTACTCTCTATCACTGATAGGGACCCTATAGTGAGTCGTATTA pNFB-T7tetKS was constructed by amplifying pTetRgfp using the following oligos: 5' AAGTGTCACCTGCTAATGCTCTAGAAATAATTTTGTTTAACTTT AAGAAGGAGATATACATATGTCCAGATTAGATAAAAGTAAAGTG 5' AAGTGTCACCTGCTTTAGCGGCTTAAGACCCACTTTCACATTTAAG pKSGFP was amplified using the following oligos: 5' AAGTGTCACCTGCATATCCGCTCTAGAAATAATTTTGTTTAAC 5' AAGTGTCACCTGCATATGAGCGGTCTCTATCACTGATAGGGACCCTATAGTGAGTCGTATTACGCG The PCR products were digested with AarI, and the purified digestion products were then ligated.
placOLacIGFP was constructed by amplifying the EGFP coding sequence from pKSGFP, amplifying the LacI coding sequence from pT7LacI, and inserting the EGFP and LacI products into pET15b between NdeI and HindIII sites to construct the intermediate plasmid placOLacIGFPpET15b. The placOLacIGFPpET15b plasmid was then digested using BglII and HindIII, and the digestion product containing the T7 promoter-LacO-RBS-LacI-RBS-GFPTerminator sequence was inserted into pET3a.
S2. Temperature of Cell-Free Reactions
Although a cell-free reaction temperature of 37°C was recommended by the kit manufacturer for maximizing expression yield, we chose to perform reactions at 30°C. This was done to aid in proper protein folding. Figure S1 compares the expression dynamics of our benchmark construct at 30°C and 37°C. Fluorescence was significantly more intense at 30°C, most likely due to more efficient GFP folding (91, 92) . Figure S1: Dynamics of cell-free reaction using the Promega T7S30 High-Yield expression system and the benchmark plasmid pDEST17-EGFP. Triplicate results are shown for 30°C and 37°C.
S3. Reporter Experiments
We compared three different GFP variants: EGFP, GFPmut3.1(ASV), and superfolder GFP. The constructs used to compare these (pT7tetKS, pT7tetKS-ASV, and pT7tetKS-SF respectively) differed only in the reporter gene. EGFP gave the brightest fluorescence in our experiments.
Figure S2:
Comparison of EGFP, GFPmut3.1(ASV), and superfolder GFP using plasmids pT7tetKS, pT7tetKS-ASV, and pT7tetKS-SF respectively. 
S4. DNA Concentration
For all cell-free expression experiments, we used the manufacturer recommended DNA concentration, 20 ng/µL. We tested the effect of DNA concentration on expression for several different constructs, and our results in Figure S3 support that this concentration is close to optimal for our constructs. As shown in this figure, additional amounts of DNA beyond 20 ng/µL do not result in increased fluorescence for our constitutive benchmark construct pDEST17-EGFP or for the TetR repressible constructs pT7tet-g10RBS and pUC-T7tet. For the negative feedback construct pNFB-T7tet, additional amounts of DNA beyond 20 ng/uL only slightly increased fluorescence under inducing conditions (1333 ng/mL aTc). 
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S5. Comparison of Multicistronic and Multi-Plasmid Approaches
To further compare the multicistronic and multi-plasmid approaches to system composition, we expressed the bicistronic constructs pLacI-GFP and pGFP-LacI in the concentrations shown in Figure S4 . We also co-expressed pKSGFP and pLacI with each plasmid at the concentration shown in Figure S4 . Thus, each location on the x-axis corresponds to an equal number of copies of the EGFP and lacI genes for pLacI-GFP, pGFP-lacI, and pKSGFP/pLacI. Significantly higher expression, as measured by fluorescence after 10 hours of expression, was realized with the bicistronic constructs.
Figure S4:
Comparison of bicistronic and two-plasmid systems. Normalized fluorescence after 10 hours of expression is shown for the bicistronic constructs pLacI-GFP and pGFP-lacI, along with the two-plasmid system pKSGFP/pLacI. Trendlines were generated in Matlab by smoothening the data using locally weighted scatterplot smoothing (LOWESS) with a span of 6, setting fluorescence to 0 at for the 0 nM plasmid concentration point, and then performing piecewise cubic Hermite interpolation. 
S6. Decay Rates
EGFP is known to have a half-life of over 24 hours (Clontech), and its decay is insignificant over the duration of our experiments. On the other hand, mRNA typically has a faster decay time, and we sought to estimate the general decay rate of mRNA in the cell-free expression system. Although mRNA decay can depend on the transcript, many cell-free expression systems have been developed to maximize messenger lifetime.
To develop a general estimate of mRNA stability in the Promega T7S30 High-Yield system, GFPmut3.1(ASV) was expressed using the plasmid pFNK-503 (90) activated by the addition of 30 µM 3OC12HSL (11,88). Once fluorescence from this construct reached levels that were at least 10 times higher than background, 1 µg/mL rifampicin was added to inhibit further transcription. Fluorescence was measured every two minutes.
Assuming negligible EGFP decay and a stationary translation rate over the 1-2 hour duration of these experimental measurements, the dynamics of fluorescence following rifampicin addition at time t=0 should be described by Equations 1-2 below. Here, m is the mRNA concentration and p is GFP fluorescence, which we assume scales linearly with GFP protein concentration:
Solving for p(t) gives the following:
Equation 3 described the data well for all 10 experiments performed, as shown for one experiment in Figure S5 . For each experiment, the initial fluorescence p(0) was subtracted, and the data was fit to Equation 3 with p(0)=0. The mRNA half-life was then calculated as ln(2)/γ, and the average from 10 experiments was 30min (std dev = 4min). This is an order of magnitude longer than typical mRNA degradation rates in live E. coli cells (93) . 
S7. Comparison of vsv and T7 terminators
To further compare the vsv and T7 terminators, we first examined transcripts produced from the pUCT7tet (vsv terminator) and pUCT7tet-T7term (T7 terminator) constructs using the Ambion MAXIscript T7 in vitro transcription kit. The upper main transcript band of the gel shown in Figure S6a corresponds to unterminated transcripts, while the lower main transcript band corresponds to properly terminated transcripts. No significant difference was revealed.
We then examined transcripts from these constructs using the Promega T7S30 High Yield expression system. As shown in Figure S6b , the only construct that yielded an observable band was circular pUCT7tet-T7term DNA (lane 4). The greater transcript yield and higher expression levels observed with the T7 terminator constructs can be partially explained by a lower mRNA degradation rate. To quantify the effect of the terminator sequence on mRNA stability, we used the approach presented in Section S6, except that 390 µM T7 lysozyme was used to inhibit transcription. Triplicate measurements revealed that the half-life of mRNA from the T7 terminator construct pUCT7tet-T7term was 28% longer than the half-life of mRNA from the vsv construct pUCT7tet, as shown in Figure S6c . 
S8. Negative Feedback with the Lac Repressor
We primarily focused on optimizing a TetR repressible T7 promoter and building feedback with this promoter, as Tet repressible T7 promoters have not been previously characterized. Also, the Promega T7S30 High Yield kit, which was used for all cell extract experiments, has IPTG preadded. This precludes proper characterization of the Lac constructs. However, to demonstrate that feedback based on T7 transcription works with the Lac system, we constructed a negative feedback plasmid (placOLacIGFP described in Table S6 ) using the T7lacO1 promoter shown in Figure 2 . Results in live BL21-AI cells (Invitrogen) are shown below. The control constructs pLacOGFP (Table S3 ) and pLacI-GFP (Table S5 ) exhibited no increase in fluorescence in response to IPTG, but the feedback construct placOLacIGFP showed five-fold induction with the addition of 30 µM IPTG. Further optimizations could be performed to improve the dynamic range of induction, such as the testing of different T7lac promoter variants and optimization of ribosome binding sites.
The plasmids pLacOGFP, pLacI-GFP, and placOLacIGFP were each transformed into chemically competent BL21-AI E. coli. Single colonies from each transformation plate were inoculated into 2 mL LB media with 100 µg/mL ampicillin and grown to log phase at 37ºC with shaking at 250 RPM. The cultures were then diluted 1:100 into 2 mL of M9 media (recipe described in Materials and Methods) with 100 µg/mL ampicillin and grown to log phase at 37°C with shaking. These cultures were diluted to an OD of ~0.01, and 1 mM L-arabinose was added to induce the expression of T7 polymerase. Aliquots (200 µL) were then dispensed into the wells of a 96-well plate (Corning 3370). The inducer IPTG was added as indicated in Figure S7 . 50 µL of mineral oil was added to prevent evaporation. Plate reader measurements were taken as described in Materials and Methods, and the measurements in Figure S7 were taken after 2 hours of growth. Fluorescence values were corrected for background fluorescence, and absorbance readings at 600 nm were used to normalize for cell density. The resulting values were then divided by the fluorescence/absorbance measurement for the pLacOGFP sample with no IPTG.
Figure S7: Control T7lacO1-GFP construct (pLacOGFP), control T7-lacI-GFP construct (pLacI-GFP), and T7lacO1-lacI-GFP negative feedback construct (placOLacIGFP) in live BL21-AI E. coli grown with 1 mM arabinose and IPTG as indicated. Error bars depict standard deviation of four measurements.
S9. Fluorescence of Inducer aTc
We verified that the fluorescence of the aTc inducer is insignificant compared to the intensity of GFP fluorescence produced from the feedback constructs. As shown in Figure S8 , the normalized fluorescence value of the highest aTc concentration used in this study (3300 ng/mL) was 0.004. This is over an order of magnitude less than the fluorescence of the fully induced feedback constructs.
Figure S8:
Normalized fluorescence of reaction mix with no DNA and reaction mix with no DNA and the highest aTc concentration used in this study, 3300 ng/mL. Readings were taken after 10 hours of incubation with shaking at 30°C. 
